Its activation can increase tumor antigen presentation, promote infiltration of effector T lymphocytes, and synergize with immune checkpoint inhibitors such as PD-1/PD-L1 blockade; however, excessive or chronic stimulation may also trigger immunosuppressive effects, including PD-L1 upregulation and regulatory T-cell expansion. The gene discussed is CD274; the disease is neoplasm.